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Abstract
Background:  In the past few years, both automated and manual high-throughput protein
expression and purification has become an accessible means to rapidly screen and produce soluble
proteins for structural and functional studies. However, many of the commercial vectors encoding
different solubility tags require different cloning and purification steps for each vector, considerably
slowing down expression screening. We have developed a set of E. coli expression vectors with
different solubility tags that allow for parallel cloning from a single PCR product and can be purified
using the same protocol.
Results: The set of E. coli expression vectors, encode for either a hexa-histidine tag or the three
most commonly used solubility tags (GST, MBP, NusA) and all with an N-terminal hexa-histidine
sequence. The result is two-fold: the His-tag facilitates purification by immobilised metal affinity
chromatography, whilst the fusion domains act primarily as solubility aids during expression, in
addition to providing an optional purification step. We have also incorporated a TEV recognition
sequence following the solubility tag domain, which allows for highly specific cleavage (using TEV
protease) of the fusion protein to yield native protein. These vectors are also designed for ligation-
independent cloning and they possess a high-level expressing T7 promoter, which is suitable for
auto-induction. To validate our vector system, we have cloned four different genes and also one
gene into all four vectors and used small-scale expression and purification techniques. We
demonstrate that the vectors are capable of high levels of expression and that efficient screening
of new proteins can be readily achieved at the laboratory level.
Conclusion:  The result is a set of four rationally designed vectors, which can be used for
streamlined cloning, expression and purification of target proteins in the laboratory and have the
potential for being adaptable to a high-throughput screening.
Background
The establishment of rapid expression and purification
procedures for recombinant proteins has become a major
challenge for biotechnology and indeed any laboratory
which studies proteins. The genomic and structural
genomic communities have driven the development of
high-throughput cloning, expression and purification
technologies to a large extent. Recent developments
including filter-plate based assays for cloning, expression
and purification, ligation-independent cloning (LIC) [1],
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Gateway technology [2] and auto-induction for protein
expression [3] are now readily coupled to robotic pipe-
lines that have made the parallel production of proteins a
relatively simple, cost-effective approach. E. coli remains
the system of first-choice for expressing proteins, as it is
cheap and easy to handle, however many mammalian
proteins cannot be successfully expressed in E. coli [4].
This leaves the researcher to either explore expression
space using a range of alternative E. coli strains, different
temperatures, solubility tags or choose an alternative
expression host [5,6].
There are numerous commercial and non-commercial E.
coli expression vectors available that incorporate fusion
tags (for both purification and enhanced solubility), Gate-
way or LIC technologies, protease cleavage sequences and
regulable expression levels [7]. These vectors are generally
designed to be used in diverse expression/purification
applications and thus often contain extraneous sequences
at either the N- or C-termini of the protein. In addition,
the use of different fusion tags mean that alternative puri-
fication protocols are required for each protein expressed
from a different vector, increasing the time it takes to find
Basic expression vector design Figure 1
Basic expression vector design. (A) The basic vector design for the pLIC vectors. (B) Shows the nucleotide sequence for 
the features common to all the vectors. The pLIC-His vector is identical in sequence except it does not contain the NcoI-SpeI 
restriction enzyme sites between the His tag and the TEV recognition sequence.
  AGATCTCGATCCCGCGAAAT TAATACGACTCACTATAG GGGAATTGTGAGCGGATAACAATTCCCC TCTAGAAATAATTTTGTTTAACTTTAAG
  AAGGAG ATATACAT ATG CAC CAT CAC CAT CAC CAT GGA  ACT AGT GAA AAC CTG TAT TTC CAG GGA GCA  GCC GCG GCC GGT GCT
                                                HIS   HIS    HIS   HIS    HIS   HIS    GLY   THR  SER  GLU  LYS   LEU   TYR PHE GLN  GLY   ALA    ALA  
             BamHI
  TTG CAG GATCCGAATCGAGCTCCGTCGACAAGCTTGCGGCCGCACTCGAGCACCACCACCACCACCACCTGAGATCCGGCTGCTAACAAAGC
  CCGAAAGGAAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTG 
RBS                   Nde I                  His Tag                 NcoI
T7 terminator
    SpeI              TEV recognition site                        SacII (LIC)
  Bglll              T7 promoter                                lac  operator                     XbaI
A
B
pLIC-GST
T 7 ATG His TEV LIC
T 7 ATG His Linker TEV LIC
GST
MBP
Nus
pLIC-His
pLIC-MBP
pLIC-Nus
Predicted molecular weights of the  fusion tags
His-TEV-LIC 1992 Da
GST-TEV-LIC 27978 Da
MBP-TEV-LIC 44907 Da
Nus-TEV-LIC 56832 DaBMC Biotechnology 2006, 6:12 http://www.biomedcentral.com/1472-6750/6/12
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successful expression and purification conditions. As a
result of these limitations, we set out to create a set of E.
coli expression vectors that incorporate these essential fea-
tures: i) protein expressed from each vector is initially
purified in the same manner; ii) the cloning procedure is
the same for all vectors and iii) a range of solubility tags
are available. Moreover these vectors have been developed
for use at the general laboratory level so that a researcher
can rapidly screen a range of expression conditions.
Here, we describe a set of four rationally designed expres-
sion vectors for E. coli. The first, (pLIC-His) encodes for a
hexa-His tag followed by a TEV recognition sequence. The
other three encode for three common solubility tags [MBP
[8], NusA [9], GST [10] plus a TEV recognition sequence.
TEV protease was selected due its superior specificity and
adaptability to a range of buffering conditions [11]. The
vectors are LIC compatible, and contain an N-terminal
hexa-His tag enabling parallel cloning and purification,
expression is via a T7 promoter allowing for auto-induc-
tion and they all possess a TEV recognition site between
the fusion partner and the gene of interest. These features
make the vectors ideally suitable for high-throughput
cloning and expression screening.
We demonstrate that soluble expression was observed for
a range of proteins and that they could be readily digested
with TEV to yield the native protein. In addition, we illus-
trate the relevance of parallel cloning in deciding on a sol-
ubility tag that is suitable for a target protein. This
demonstrates that the vectors can be used successfully at
the laboratory level to rapidly screen target proteins (or
Ligation-Independent Cloning (LIC) Methodology Figure 2
Ligation-Independent Cloning (LIC) Methodology. Shows the general procedure for LIC (1) The primer sequences 
required for amplification of the gene of interest. (2) Both the vector and insert are subject to treatment with T4 DNA 
polymerase, in the presence of either dTTP (vector) or dATP (insert). (3) The result after successful annealing. (4) After cleav-
age with TEV protease, the tags are removed and the protein retains 4 amino acids (GAAS).BMC Biotechnology 2006, 6:12 http://www.biomedcentral.com/1472-6750/6/12
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their mutants) and can be readily adapted to the high-
throughput process.
Results and discussion
Construction of the pLIC vectors and His-HHR23A, GST-
UIM, MBP-α1-AT and Nus-UBL
Several vector systems have been described that incorpo-
rate a variety of backbones, promoters, tag positions and
cloning procedures. One drawback from several of these
studies is the lack of consistency within the vector systems
which does not allow a systematic study of protein expres-
sion [12-15]. Thus the aim of this study was to generate a
set of vectors which enable parallel cloning of a given tar-
get(s) and enables a comparative analysis of the expres-
sion yields using different solubility tags. As a result, the
pLIC set of prokaryotic vectors were created using
pET21b(+) as their host. An oligonucleotide cassette was
used to introduce the His tag, TEV site and LIC site as well
as two unique restriction sites (NcoI-SpeI). These unique
sites were used to introduce either the genes encoding for
the GST, MBP or Nus tags and could in principle, be used
to introduce alternative tags. The four vectors, termed
pLIC-His, pLIC-GST, pLIC-MBP and pLIC-Nus were cre-
ated as shown in Figure 1. It is to our knowledge, the first
Small scale expression, purification and cleavage of recombinant proteins Figure 3
Small scale expression, purification and cleavage of recombinant proteins. (A) SDS-PAGE analysis of the total cell 
lysate (T), insoluble (I), soluble (S), and the purified (P) fractions for each of the fusions: His-HHR23a, GST-UIM, MBP-α1-AT 
and Nus-UBL (the protein is marked with an asterisk). (B) SDS-PAGE analysis of each fusion during TEV protease digestion, (1) 
intact fusion (2) TEV digestion (3) purified protein after digestion. The band around 30 kDa observed in lane 2 of each experi-
ment corresponds to the TEV protein.
A
B
MBP-α1-AT Nus-UBL HIS-HHR23a GST-UIM
*
*
*
*
36.5
55.4
66.3
97.4
(kDa)
1 2312312 3 12 3
His-HHR23a GST-UIM MBP-α1-AT Nus-UBL
55.4
(kDa)
36.5
66.3
97.4
31.0
21.5
14.4
6.0
T     I    S   P  T     I    S   P  T     I    S  P  T     I    S   P BMC Biotechnology 2006, 6:12 http://www.biomedcentral.com/1472-6750/6/12
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set of E. coli expression vectors derived from the same
backbone, with the only variation being in the solubility
tag present. The genes HHR23A, UIM, α1-AT and UBL
were subsequently amplified and successfully introduced
into each of the vectors using LIC. In addition, HHR23A
was cloned into all vectors simultaneously to monitor the
effect that different tags had on the solubility of this par-
ticular protein.
Two recently developed ligation methods (Gateway tech-
nology (Invitrogen) and LIC) have been used extensively
by the structural genomics community. Both techniques
offer the opportunity for parallel cloning, such that multi-
ple targets can be easily cloned into several different vec-
tors. With the LIC strategy in particular, target genes are
amplified with 12–15 bp end sequences and the 5'-3'
endonuclease activity of T4 DNA polymerase is then
exploited [1,16] (Figure 2). This digestion event generates
overhangs in the PCR product that allows subsequent
insertion into a complementarily digested vector using a
simple annealing step. As there is no need for restriction
enzymes or ligation steps, LIC is a highly efficient and cost
effective means of cloning. It also has the advantage that
it does not require expensive reagents or multiple manip-
ulations.
The LIC technique was found to be an efficient process in
our hands, whereby up to 80% of the colonies screened
were found to be positive. We observed, however, that
success in LIC lies in the quality of the linearized vector,
which was dependent, in part, on using a vast excess of
SacII enzyme. Gel purification was used in the prepara-
tion of the vector and insert and it serves three purposes:
by removing unwanted (and possibly active) DNA
polymerase, removing excess dNTPs and selecting the cor-
rect PCR product over other misprimed events or linear-
ized vector over undigested material. In a high-
throughput format, a sizeable quantity of PCR product
would be generated (and can be verified by sequencing)
prior to parallel cloning into the vectors.
Expression and purification of the constructs
Each of the constructs was transformed into the E. coli
host BL21(DE3) and expressed in 2 ml of auto-induction
expression media. Following expression, the cell density
of each of the cultures were normalised to an OD600 nm of
5.0 prior to lysis, which allowed for a uniform number of
cells between each sample. The cultures were chemically
lysed using PopCulture (Novagen), which is a chemical
method for lysis and particularly useful for multiple sam-
ples. After lysis, the cell lysates were subjected to a solubil-
Parallel expression, purification and cleavage of HHR23A Figure 4
Parallel expression, purification and cleavage of HHR23A. HHR23A was cloned into all 4 vectors and the constructs 
were expressed and purified as described in the materials and methods. SDS-PAGE analysis of the total cell lysate (T), insoluble 
(I), soluble (S), and the purified (P) fractions for each of the fusions are shown.
A
55.4
(kDa)
36.5
66.3
97.4
31.0
MBP-HHR23a Nus-HHR23a His-HHR23a GST-HHR23a
*
*
*
*
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ity assay (as described in the Materials and Methods) to
assess the relative proportions of soluble and insoluble
expression. As shown in Figure 3A, all of the constructs
were found to have soluble expression, as judged by pres-
ence of a respective bands at the predicted molecular
weights. Both His-HHR23A and MBP-α1-AT have margin-
ally greater proportions of insoluble material, whilst Nus-
UBL and GST-UIM have slightly elevated proportions of
soluble material. Optimization of soluble yields was not
performed in this study, as this can vary greatly from pro-
tein to protein. It has been recently been shown however,
that a lower temperature used during auto-induction may
improve the yield of soluble material [3]. The soluble
expression and purification of MBP-αl-AT was particular
interesting, as αl-AT is generally produced in very high
yields in an insoluble form and purified using a refolding
method [17,18].
In addition to screening different targets in each of the
vectors, we also cloned a single gene (HHR23A) into all
four vectors. As can be seen in Figure 4, HHR23A
expressed largely as inclusion bodies, however soluble
material was obtained in all four vectors. More impor-
tantly however, is that the tags had differing effects on the
expression of HHR23A. In this instance, GST was found to
be the most efficient in improving the expression whereas
NusA had little additional benefit (Figure 4). This illus-
trates therefore, the usefulness of parallel cloning and
expression, as a protein may express more favourably with
a different tag.
An additional observation of the small-scale expression
was the importance for a purification step (Ni-NTA). In
some cases, soluble expression of the protein showed a
very faint band in the soluble fraction, but was purified at
more detectable quantities (see α1-AT band, Figure 3A).
This however, appears to be dependent on the degree of
soluble expression, as the UBL and UIM constructs for
instance, showed very clear results in the solubility assay
(Figure 3A). The use of the solubility assay in isolation
should thus be used with caution, particularly for a poorly
expressing protein that may produce unclear results. In
some cases, it may be useful to complement the assay with
a Western blot.
TEV cleavage
Generally, affinity tags are removed after purification as
they can interfere with either the protein's function or
with downstream processes. The most common example
is if the protein is to be used for crystallographic or NMR
studies. While there have been reports of proteins being
crystallized with the assistance of an affinity tag [19-21]
the general view is that they should be removed [22]. Each
of the constructs described above has a TEV cleavage site
which can be used to remove the affinity tags, leaving the
native protein with 4 vector-derived residues (GAAS) (Fig-
ure 1). This is comparable to another LIC vector available
which describes 3 vector-derived residues (S-N-A) [14].
Indeed the introduction of non-native amino acids at the
N- terminus is not ideal and it is a common problem that
generally exists both for the LIC and Gateway technolo-
gies. As a result, the effect of such residues (both in
number and composition) on the expression, purification
and integrity of a given protein must be verified experi-
mentally [12].
To validate the TEV cleavage site, each of the proteins were
digested with his-tagged TEV protease and purified. As
seen in Figure 3B, after cleavage three species are present:
the solubility tag (26 kDa GST, 42 kDa MBP, 54 kDa
NusA), the his-tagged TEV protease (30 kDa) and the pro-
tein of interest. This mixture can be purified further to
remove the his-tagged TEV protease and the solubility tag
by selectively binding them to a Ni-NTA column. The pro-
tein of interest, on the other hand remains unbound to
the Ni resin as it lacks a His tag (Figure 3B).
It is should be noted that although a given protein target
may express solubly, its behaviour in the absence of the
solubility tag may be very different, as this is a function of
other factors (structure, amino acid sequence, aggregation
potential, buffering conditions). Thus the integrity of the
protein after TEV cleavage should be verified using other
methods (dynamic light scattering, size exclusion chro-
matography, circular dichroism etc.).
Conclusion
Here, we have presented a set of four rationally designed
T7-based E. coli expression vectors whose features include
the incorporation of solubility tags to assist in expression/
purification, a TEV cleavable sequence and a LIC
sequence. We have shown soluble expression and purifi-
cation of four different proteins as well the ability to
remove the tags using TEV protease. These vectors allow
for rapid parallel cloning and expression and are suitable
for either laboratory-scale screening of target proteins, or
alternatively for high-throughput screening.
Methods
Construction of pLIC-HIS and pLIC-MGN
The vector pET21b(+) (Novagen) was used as the basis for
the pLIC vectors. pET21b(+) was manipulated to produce
two different constructs, pLIC-His and pLIC-MGN. For the
pLIC-HIS construct, the vector's unique NdeI-BamHI
restriction sites were used. An oligonucleotide cassette con-
taining the His-tag, TEV and LIC sites was created and
ligated into the vector which had been previously digested
with NdeI-BamHI (Figure 1). The cassette was comprised
of the following oligonucleotides: 5'-
tatgcaccatcaccatcaccatgaaaacctgtatttccagggagcagccgcggccg-BMC Biotechnology 2006, 6:12 http://www.biomedcentral.com/1472-6750/6/12
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gtgctttgcag-3' and 3'-acgtggtagtggtagtggtacttttggacataaaggtc-
cctcgtcggcgccggccacgaaacgtcctag-5'. pLIC-MGN was created
by utilising the same NdeI-BamHI sites, but incorporating
a cassette of the following oligonucleotides: 5'-
tatgcaccatcaccatcaccatggaactagtgaaaacctgtatttccagggag
cagccgcggccggtgctttgcag-3' and 3'-acgtggtagtggtagtggtacctt-
gatcacttttggacataaagg tccctcgtcggcgccggccacgaaacgtcctag-3'.
This cassette encodes the His tag, a unique NcoI site, a
unique SpeI site, TEV recognition sequence and the LIC site
(Figure 1). It was also ligated into pET21b(+).
Construction of pLIC-GST, pLIC-MBP and pLIC-Nus
The introduction of the unique NcoI and SpeI site in
pLIC-MGN allowed for the introduction of the solubility
tags: GST, MBP and NusA. The GST gene was cloned from
the vector pET41 (Novagen), the MBP gene from pMAL-
2cx (New England Biolabs) and NusA from pET43.1
(Novagen). The oligonucleotides used for the amplifica-
tion are presented in Additional file 1. As the NusA gene
already contained a NcoI site, the QuikChange site-
directed mutagenesis technique (Stratagene) was used to
remove this site, using the vendor's instructions. Briefly,
the plasmid was amplified using a pair of complementary
primers (See Additional file 1) and using the polymerase
Pfu. The PCR product was then digested with 10 u of
DpnI, followed by transformation into competent DH5α
E. coli.
The genes encoding GST, MBP and NusA were amplified
and each of the PCR products were subjected to sequential
digestion with NcoI and SpeI followed by gel purification
and ligation into the pLIC-MGN vector. This yielded three
different constructs termed: pLIC-GST, pLIC-MBP and
pLIC-Nus.
Cloning of UIM, α1-AT, HHR23A and UBL into the vectors
To clone into the expression vectors, PCR products of the
gene of interest need to be generated with specific over-
hangs that are complementary to the sequence of the vec-
tor (Figure 2). After cleavage with TEV, the native protein
will have four vector-derived residues (G-A-A-S). To vali-
date the vectors, four genes were chosen to be expressed:
HHR23A was cloned into pLIC-His, ubiquitin interacting
motif (UIM) into pLIC-GST, α1-antitrypsin (α1-AT) in
pLIC-MBP and ubiquitin-like domain from HHR23A
(UBL) into pLIC-NUS.
The LIC site consists of a unique SacII site, which can be
used to linearize the vector and thus permit T4 DNA
polymerase treatment to take place (Figure 2). 30 units of
SacII (New England Biolabs) was used to digest 1 µg of the
target vector in a total reaction volume of 50 µl for a total
of 3 hours. The linearized vector was then separated and
gel purified from an agarose gel and the DNA concentra-
tion determined using UV-spectroscopy. 0.2 pmol of DNA
was then treated with T4 DNA Polymerase (1 u/0.1 pmol
DNA) and 2.5 mM dTTP at 22°C for 30 minutes followed
by heat inactivation for 20 minutes.
Each of the four genes was amplified using Pfu polymerase
(Promega) using the oligonucleotides detailed in Addi-
tional file 1. The amplification was for 30 cycles with the
following conditions: 95°C 1 min, X°C 1 min, 72°C for
Ymins. The annealing temperatures (X) and extension
times (Y) for each of the constructs are shown in Addi-
tional file 1. After amplification, the PCR products were
gel purified prior to being treated with T4 DNA Polymer-
ase (1 u/0.1 pmol) and 2.5 mM dATP at 22°C for 30 mins,
followed by a 20 min heat inactivation step.
For the annealing process, 1 µl of T4 treated vector was
mixed with 2 µl of T4 treated PCR product and allowed to
incubate at 22°C for 1 hour. 1 µl of 25 mM EDTA pH 8.0
was then added and the reaction incubated for 5 mins.
The annealed mix was then transformed into competent
JM107 E. coli. The colonies were assessed by colony PCR
and the clones were verified using DNA sequencing.
Expression and purification of His-HHR23A, GST-UIM, 
MBP-α1AT and Nus-UBL
Each of the clones were transformed into competent
BL21(DE3) E. coli cells and streaked onto plates. A single
colony was selected and expressed in 2 ml of Overnight
Express Media (Novagen) for 18 hours at 30°C, 300 rpm.
The OD600 nm was recorded for cells after growth (typically
ranging between 8–11) and the absorbance was normal-
ised to OD600 nm = 5.0 for each, which allowed for a uni-
form number of cells between samples. The cells were
then lysed with 0.2 ml of PopCulture supplemented with
2 µl of lysozyme and benzoase, as per manufacturer's rec-
ommendation (Novagen). 200 µl of each cell lysate was
retained for the Solubility Assay (see below). The remain-
ing material was bound batch wise, to 200 µl of Ni-NTA
resin which had been previously equilibrated in buffer
(25 mM NaPO4, 500 mM NaCl pH 8.0). The slurry was
then collected in a 2 ml filter plate (supplied with the sol-
ubility assay kit, Novagen) and washed with 4 ml of buffer
supplemented with 25 mM imidazole. The proteins were
then eluted with 250 mM imidazole in 25 mM NaPO4, 50
mM NaCl pH 8.0 in a 200 µl volume.
Solubility assay
The solubility assay (Novagen) was used to determine the
relative proportions of soluble and insoluble material that
were expressed for each of the constructs. After lysis with
PopCulture, 200 µl samples of each lysate was passed
through the wells of a 0.2 µm filter plate (supplied by the
manufacturer) and collected. Here, the soluble protein
passes through the plate whilst the insoluble inclusion
bodies are retained. 200 µl of 4%(w/v) SDS was thenPublish with BioMed Central    and   every 
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added to each well and following a 10 min incubation the
insoluble proteins eluted. A sample of both the soluble
and insoluble fractions were retained for SDS-PAGE anal-
ysis.
TEV protease cleavage
The concentration of protein was estimated using the BCA
Assay (Pierce). Protein at a concentration of 0.5 mg/ml
was incubated with 0.05 mg/ml of TEV and allowed to
incubate at 4°C for 16 hours. The sample was then run on
a SDS gel to check for the completion of cleavage
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